Q32 Bio Inc.

XNAS:QTTB 4:00:00 PM EDT

5.50

-0.22 (-3.85%)

4:38:15 PM EDT: $5.60 +0.10 (+1.82%)

Q32 Bio Inc. Stock, XNAS:QTTB

830 Winter Street, 2nd floor, Waltham, Massachusetts 02451

United States of America

Phone:

Number of Employees: 42

http://www.q32bio.com

Description

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.